STAAR Surgical shares are down after preliminary Q2 net sales of over $90M versus $44.3M a year ago, indicating a sharp year-over-year increase. Despite the growth, the stock reaction suggests the move may not have met market expectations or guidance assumptions.
STAAR Surgical shares are down after preliminary Q2 net sales of over $90M versus $44.3M a year ago, indicating a sharp year-over-year increase. Despite the growth, the stock reaction suggests the move may not have met market expectations or guidance assumptions.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
